FDA.reportPublic FDA data

capsaicin 0.25 MG/ML / lidocaine hydrochloride 25 MG/ML / menthol 100 MG/ML / methyl salicylate 250 MG/ML Topical Lotion

RxCUI
1020420
RxNorm name
capsaicin 0.25 MG/ML / lidocaine hydrochloride 25 MG/ML / menthol 100 MG/ML / methyl salicylate 250 MG/ML Topical Lotion
Display name
Capsaicin/Lidocaine/Menthol/Methyl salicylate (Topical)
Full name
capsaicin 0.25 MG/ML / lidocaine hydrochloride 25 MG/ML / menthol 100 MG/ML / methyl salicylate 250 MG/ML Topical Lotion
Term type
SCD
Status
Active
Strength
0.025-2.5-10-25%
Dose form
Lotion
Route
Topical
Updated
2026-07-15 00:09:49

RxNorm Status History#

Status
Active
Source
RXNORM
Current
YES
Release start
112010
Active start
112010
Multiple ingredient
YES
Branded
NO

Ingredients And Strength#

Ingredient, Strength, Base table
IngredientStrengthBaseBasis of strength
capsaicin0.25 MG / 1 MLcapsaicincapsaicin
methyl salicylate250 MG / 1 MLmethyl salicylatemethyl salicylate
lidocaine hydrochloride25 MG / 1 MLlidocainelidocaine hydrochloride
menthol100 MG / 1 MLmentholmenthol

Dose Form Concepts#

Dose form, RxCUI table
Dose formRxCUI
Topical Lotion316983

Derived Ingredient Concepts#

Ingredient, RxCUI table
IngredientRxCUI
capsaicin1992
methyl salicylate29787
lidocaine6387
menthol6750

Source Vocabulary Codes#

Code type, Value, Category table
Code typeValueCategory
PRESCRIBABLEYATTRIBUTES
RXNAV_STRcapsaicin 0.25 MG/ML / lidocaine hydrochloride 25 MG/ML / menthol 100 MG/ML / methyl salicylate 250 MG/ML Topical LotionNAMES
RxNorm Namecapsaicin 0.25 MG/ML / lidocaine hydrochloride 25 MG/ML / menthol 100 MG/ML / methyl salicylate 250 MG/ML Topical LotionNAMES
RxNorm Synonymcapsaicin 0.025 % / lidocaine HCl 2.5 % / menthol 10 % / methyl salicylate 25 % Topical LotionNAMES
TTYSCDATTRIBUTES
RxCUI1020420CODES
MMSL_CODEBD27249CODES
MMSL_CODECD27249CODES

RxNav Current And Historical NDCs#

NDC11, Source, Active table
NDC11SourceActive
63629447101rxnav_ndcsyes
33261086201rxnav_historical
35356054201rxnav_historical
42549069204rxnav_historical
50436999501rxnav_historical
50488123101rxnav_historical
68258398804rxnav_historical
68788949601rxnav_historical

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set IDRxNorm stringTTYSPL versionLabelEffective
b24f5cfc-7957-4f65-9968-cf1084e69128capsaicin 0.025 % / lidocaine HCl 2.5 % / menthol 10 % / methyl salicylate 25 % Topical LotionSY2Terocin Topical Pain Relief Lotion20101001
b24f5cfc-7957-4f65-9968-cf1084e69128capsaicin 0.25 MG/ML / lidocaine hydrochloride 25 MG/ML / menthol 100 MG/ML / methyl salicylate 250 MG/ML Topical LotionSCD2Terocin Topical Pain Relief Lotion20101001
b24f5cfc-7957-4f65-9968-cf1084e69128capsaicin 0.025 % / lidocaine HCl 2.5 % / menthol 10 % / methyl salicylate 25 % Topical LotionPSN2Terocin Topical Pain Relief Lotion20101001
1402d6fc-73e9-4702-a2e3-71485d37122fcapsaicin 0.025 % / lidocaine HCl 2.5 % / menthol 10 % / methyl salicylate 25 % Topical LotionPSN1Terocin Topical Pain Relief Lotion20140325
1402d6fc-73e9-4702-a2e3-71485d37122fcapsaicin 0.25 MG/ML / lidocaine hydrochloride 25 MG/ML / menthol 100 MG/ML / methyl salicylate 250 MG/ML Topical LotionSCD1Terocin Topical Pain Relief Lotion20140325
1402d6fc-73e9-4702-a2e3-71485d37122fcapsaicin 0.025 % / lidocaine HCl 2.5 % / menthol 10 % / methyl salicylate 25 % Topical LotionSY1Terocin Topical Pain Relief Lotion20140325

DailyMed Labels#

Set ID, Title, Manufacturer table
Set IDTitleManufacturerEffective
1402d6fc-73e9-4702-a2e3-71485d37122fTerocin Topical Pain Relief LotionPreferred Pharmaceuticals, Inc.20140325
b24f5cfc-7957-4f65-9968-cf1084e69128Terocin Topical Pain Relief LotionUnit Dose Services20101001

Drug Classes#

Source, Class ID, Class table
SourceClass IDClassTypeRelationshipDrug concept
ATCN01BBAmidesATC1-4lidocaine
ATCS02DAAnalgesics and anestheticsATC1-4lidocaine
ATCD04ABAnesthetics for topical useATC1-4lidocaine
ATCR02ADAnesthetics, localATC1-4lidocaine
ATCC01BBAntiarrhythmics, class IbATC1-4lidocaine
ATCM02ABCapsaicin and similar agentsATC1-4capsaicin
ATCS01HALocal anestheticsATC1-4lidocaine
ATCC05ADLocal anestheticsATC1-4lidocaine
ATCN01BXOther local anestheticsATC1-4capsaicin
FDASPLN0000175682Amide Local AnestheticEPChas_epclidocaine
FDASPLN0000175426AntiarrhythmicEPChas_epclidocaine
FDASPLN0000175976Local AnesthesiaPEhas_pelidocaine
MEDRTD002211CapsaicinCHEMhas_ingredientcapsaicin
MEDRTD008012LidocaineCHEMhas_ingredientlidocaine
MEDRTD008012LidocaineCHEMhas_ingredientlidocaine hydrochloride
MEDRTD008610MentholCHEMhas_ingredientmenthol
MEDRTD012459SalicylatesCHEMhas_ingredientmethyl salicylate
MEDRTD059787Acute PainDISEASEmay_treatmethyl salicylate
MEDRTD000219Adams-Stokes SyndromeDISEASEci_withlidocaine
MEDRTD000219Adams-Stokes SyndromeDISEASEci_withlidocaine hydrochloride
MEDRTD001168ArthritisDISEASEmay_treatmethyl salicylate
MEDRTD001416Back PainDISEASEmay_treatmethyl salicylate
MEDRTD002056BurnsDISEASEmay_treatlidocaine
MEDRTD002056BurnsDISEASEmay_treatlidocaine hydrochloride
MEDRTD003288ContusionsDISEASEmay_treatmethyl salicylate
MEDRTD003929Diabetic NeuropathiesDISEASEmay_treatcapsaicin
MEDRTD004342Drug HypersensitivityDISEASEci_withlidocaine
MEDRTD004342Drug HypersensitivityDISEASEci_withcapsaicin
MEDRTD004342Drug HypersensitivityDISEASEci_withmethyl salicylate
MEDRTD004342Drug HypersensitivityDISEASEci_withlidocaine hydrochloride
MEDRTD004342Drug HypersensitivityDISEASEci_withmenthol
MEDRTD064420Drug-Related Side Effects and Adverse ReactionsDISEASEmay_treatlidocaine hydrochloride
MEDRTD064420Drug-Related Side Effects and Adverse ReactionsDISEASEmay_treatlidocaine
MEDRTD004935Esophageal DiseasesDISEASEmay_treatlidocaine
MEDRTD004935Esophageal DiseasesDISEASEmay_treatlidocaine hydrochloride
MEDRTD006562Herpes ZosterDISEASEmay_treatcapsaicin
MEDRTD006967HypersensitivityDISEASEci_withlidocaine
MEDRTD006967HypersensitivityDISEASEci_withlidocaine hydrochloride
MEDRTD007249InflammationDISEASEmay_treatmethyl salicylate
MEDRTD009059Mouth DiseasesDISEASEmay_treatlidocaine hydrochloride
MEDRTD009059Mouth DiseasesDISEASEmay_treatlidocaine
MEDRTD009120Muscle CrampDISEASEmay_treatmethyl salicylate
MEDRTD009203Myocardial InfarctionDISEASEmay_treatlidocaine hydrochloride
MEDRTD009437NeuralgiaDISEASEmay_treatcapsaicin
MEDRTD010146PainDISEASEmay_treatlidocaine hydrochloride
MEDRTD010146PainDISEASEmay_preventlidocaine hydrochloride
MEDRTD010146PainDISEASEmay_treatmenthol
MEDRTD010146PainDISEASEmay_preventcapsaicin
MEDRTD010146PainDISEASEmay_preventlidocaine
MEDRTD010146PainDISEASEmay_treatlidocaine
MEDRTD012871Skin DiseasesDISEASEmay_treatmenthol
MEDRTD013180Sprains and StrainsDISEASEmay_treatmethyl salicylate
MEDRTD013614Tachycardia, ParoxysmalDISEASEmay_treatlidocaine hydrochloride
MEDRTD013614Tachycardia, ParoxysmalDISEASEmay_treatlidocaine
MEDRTD017180Tachycardia, VentricularDISEASEmay_treatlidocaine
MEDRTD017180Tachycardia, VentricularDISEASEmay_treatlidocaine hydrochloride
MEDRTD018754Ventricular DysfunctionDISEASEmay_treatlidocaine hydrochloride
MEDRTD014693Ventricular FibrillationDISEASEmay_treatlidocaine hydrochloride
MEDRTD014693Ventricular FibrillationDISEASEmay_treatlidocaine
MEDRTD018879Ventricular Premature ComplexesDISEASEmay_treatlidocaine
MEDRTD018879Ventricular Premature ComplexesDISEASEmay_treatlidocaine hydrochloride
MEDRTN0000000069Calcium Channel AntagonistsMOAhas_moamenthol
MEDRTN0000000160Cyclooxygenase InhibitorsMOAhas_moamethyl salicylate
MEDRTN0000000105Neurotransmitter Transporter InteractionsMOAhas_moacapsaicin
MEDRTN0000000108Prostaglandin Receptor AntagonistsMOAhas_moamethyl salicylate
MEDRTN0000000180Sodium Channel InteractionsMOAhas_moalidocaine
MEDRTN0000000180Sodium Channel InteractionsMOAhas_moalidocaine hydrochloride
MEDRTN0000008330Cardiac Rhythm AlterationPEhas_pelidocaine
MEDRTN0000008330Cardiac Rhythm AlterationPEhas_pelidocaine hydrochloride
MEDRTN0000008472Decreased Cardiac Muscle Organized Electrical ActivityPEhas_pelidocaine
MEDRTN0000008472Decreased Cardiac Muscle Organized Electrical ActivityPEhas_pelidocaine hydrochloride
MEDRTN0000008836Decreased Prostaglandin ProductionPEhas_pemethyl salicylate
MEDRTN0000008889Decreased Sensory-Somatic Nervous System Organized Electrical ActivityPEhas_pelidocaine hydrochloride
MEDRTN0000008889Decreased Sensory-Somatic Nervous System Organized Electrical ActivityPEhas_pecapsaicin
MEDRTN0000008889Decreased Sensory-Somatic Nervous System Organized Electrical ActivityPEhas_pelidocaine
MEDRTN0000008889Decreased Sensory-Somatic Nervous System Organized Electrical ActivityPEhas_pementhol
MEDRTN0000009006Decreased Thromboxane ProductionPEhas_pemethyl salicylate
MEDRTN0000175976Local AnesthesiaPEhas_pelidocaine
MEDRTN0000175976Local AnesthesiaPEhas_pelidocaine hydrochloride

Properties#

Category, Property, Value table
CategoryPropertyValue
ATTRIBUTESAVAILABLE_STRENGTH0.25 MG/ML / 25 MG/ML / 100 MG/ML / 250 MG/ML
ATTRIBUTESGENERAL_CARDINALITYMULTI
ATTRIBUTESHUMAN_DRUGUS
ATTRIBUTESPRESCRIBABLEY
ATTRIBUTESRXNAV_HUMAN_DRUGUS
ATTRIBUTESTTYSCD
CODESMMSL_CODEBD27249
CODESMMSL_CODECD27249
CODESRxCUI1020420
NAMESPrescribable Synonymcapsaicin 0.025 % / lidocaine HCl 2.5 % / menthol 10 % / methyl salicylate 25 % Topical Lotion
NAMESRXNAV_STRcapsaicin 0.25 MG/ML / lidocaine hydrochloride 25 MG/ML / menthol 100 MG/ML / methyl salicylate 250 MG/ML Topical Lotion
NAMESRxNorm Namecapsaicin 0.25 MG/ML / lidocaine hydrochloride 25 MG/ML / menthol 100 MG/ML / methyl salicylate 250 MG/ML Topical Lotion
NAMESRxNorm Synonymcapsaicin 0.025 % / lidocaine HCl 2.5 % / menthol 10 % / methyl salicylate 25 % Topical Lotion
SOURCESSourceMicromedex RED BOOK